Answers are grounded in this paper and cite their sources.
The syntheses of the cyclosporine metabolites Leu-4-cyclosporine (AM4N), (γ-OH)MeLeu-9-cyclosporine (AM9) and Leu-4-(γ-OH)MeLeu-cyclosporine (AM4N9) were completed. Aspartic acid was used as starting material to prepare peptides containing (γ-OH)MeLeu residues. The structure of metabolite M13 was definitively established as being Leu-4-(γ-OH)MeLeu-9-cyclosporine. The immunosuppressive activity in vitro of these synthesized metabolites was compared with that of cyclosporine and metabolite AM1.
No takes yet. Share an insight, caveat, or question.
Wenger et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: